Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients-Reference-Cited by-同舟云学术

Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients

Published:2008-08 Issue:7 Volume:52 Page:541-550
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Wilkoff Bruce L.,Williamson Brian D.,Stern Richard S.,Moore Stephen L.,Lu Fei,Lee Sung W.,Birgersdotter-Green Ulrika M.,Wathen Mark S.,Van Gelder Isabelle C.,Heubner Brooke M.,Brown Mark L.,Holloman Keith K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction;Moss;N Engl J Med,2002

2. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure;Bardy;N Engl J Med,2005

3. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers;Sears;Pacing Clin Electrophysiol,2000

4. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias;Lüderitz;Pacing Clin Electrophysiol,1993

5. VF and fatal cardiac arrest following ICD therapy delivery: what is the cause?;Mofrad;Pacing Clin Electrophysiol,2007

Cited by 497 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implantable Cardioverter‐Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto;Journal of the American Heart Association;2024-08-06

2. Predictors of Shock‐Reduction Programming and Its Impact on Implantable Cardioverter‐Defibrillator Therapies and Mortality: The CERTITUDE Registry;Journal of the American Heart Association;2024-08-06

3. A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial;American Heart Journal;2024-08

4. Lead Management;Cardiac Electrophysiology Clinics;2024-07

5. Decision support for personalized therapy in implantable medical devices: A digital twin approach;Expert Systems with Applications;2024-06